These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 34479551)

  • 1. An overview of genes and mutations associated with Chlamydiae species' resistance to antibiotics.
    Benamri I; Azzouzi M; Sanak K; Moussa A; Radouani F
    Ann Clin Microbiol Antimicrob; 2021 Sep; 20(1):59. PubMed ID: 34479551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in a 23S rRNA gene of Chlamydia trachomatis associated with resistance to macrolides.
    Misyurina OY; Chipitsyna EV; Finashutina YP; Lazarev VN; Akopian TA; Savicheva AM; Govorun VM
    Antimicrob Agents Chemother; 2004 Apr; 48(4):1347-9. PubMed ID: 15047540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Touchdown enzyme time release-PCR for detection and identification of Chlamydia trachomatis, C. pneumoniae, and C. psittaci using the 16S and 16S-23S spacer rRNA genes.
    Madico G; Quinn TC; Boman J; Gaydos CA
    J Clin Microbiol; 2000 Mar; 38(3):1085-93. PubMed ID: 10699002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrolide and fluoroquinolone resistance is uncommon in clinical strains of Chlamydia trachomatis.
    Deguchi T; Hatazaki K; Ito S; Kondo H; Horie K; Nakane K; Mizutani K; Tsuchiya T; Yasuda M; Yokoi S; Nakano M
    J Infect Chemother; 2018 Aug; 24(8):610-614. PubMed ID: 29627327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High treatment failure rate is better explained by resistance gene detection than by minimum inhibitory concentration in patients with urogenital Chlamydia trachomatis infection.
    Shao L; You C; Cao J; Jiang Y; Liu Y; Liu Q
    Int J Infect Dis; 2020 Jul; 96():121-127. PubMed ID: 32173573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of mutation in macrolide resistance genes in Chlamydia trachomatis clinical isolates with decreased susceptibility to azithromycin.
    Bhengraj AR; Srivastava P; Mittal A
    Int J Antimicrob Agents; 2011 Aug; 38(2):178-9. PubMed ID: 21570258
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular mechanisms of
    Mestrovic T; Ljubin-Sternak S
    Front Biosci (Landmark Ed); 2018 Jan; 23(4):656-670. PubMed ID: 28930567
    [No Abstract]   [Full Text] [Related]  

  • 8. Macrolide and fluoroquinolone associated mutations in Mycoplasma genitalium in a retrospective study of male and female patients seeking care at a STI Clinic in Guangzhou, China, 2016-2018.
    Ke W; Li D; Tso LS; Wei R; Lan Y; Chen Z; Zhang X; Wang L; Liang C; Liao Y; Chen H; Liu Y; Zheng H; Yang L
    BMC Infect Dis; 2020 Dec; 20(1):950. PubMed ID: 33308173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycoplasma pneumoniae: susceptibility and resistance to antibiotics.
    Bébéar C; Pereyre S; Peuchant O
    Future Microbiol; 2011 Apr; 6(4):423-31. PubMed ID: 21526943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of antibiotic resistance markers in Chlamydia trachomatis clinical isolates obtained after ineffective antibiotic therapy.
    Shkarupeta MM; Lazarev VN; Akopian TA; Afrikanova TS; Govorun VM
    Bull Exp Biol Med; 2007 Jun; 143(6):713-7. PubMed ID: 18239808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic approaches to Chlamydia infections.
    Senn L; Hammerschlag MR; Greub G
    Expert Opin Pharmacother; 2005 Oct; 6(13):2281-90. PubMed ID: 16218888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of point mutations in the ygeD, gyrA and parC genes in fluoroquinolones resistant clinical isolates of Chlamydia trachomatis].
    Misiurina OIu; Shipitsina EV; Finashutina IuP; Lazarev VN; Akopian TA; Savicheva AM; Govorun VM
    Mol Gen Mikrobiol Virusol; 2004; (3):3-7. PubMed ID: 15354934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of spontaneous mutations that confer antibiotic resistance in Chlamydia spp.
    Binet R; Maurelli AT
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2865-73. PubMed ID: 15980362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guided antibiotic therapy for Mycoplasma genitalium infections: Analysis of mutations associated with resistance to macrolides and fluoroquinolones.
    Piñeiro L; Idigoras P; de la Caba I; López-Olaizola M; Cilla G
    Enferm Infecc Microbiol Clin (Engl Ed); 2019; 37(6):394-397. PubMed ID: 30396750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activities of rifamycin derivatives against wild-type and rpoB mutants of Chlamydia trachomatis.
    Xia M; Suchland RJ; Carswell JA; Van Duzer J; Buxton DK; Brown K; Rothstein DM; Stamm WE
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3974-6. PubMed ID: 16127086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Chlamydial infections: 2014 update.
    Kohlhoff SA; Hammerschlag MR
    Expert Opin Pharmacother; 2015 Feb; 16(2):205-12. PubMed ID: 25579069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in 23S rRNA and ribosomal protein L4 account for resistance in Chlamydia trachomatis strains selected in vitro by macrolide passage.
    Zhu H; Wang HP; Jiang Y; Hou SP; Liu YJ; Liu QZ
    Andrologia; 2010 Aug; 42(4):274-80. PubMed ID: 20629652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in vitro activity of garenoxacin against Chlamydia spp.
    Donati M; Pollini GM; Sparacino M; Fortugno MT; Laghi E; Cevenini R
    J Antimicrob Chemother; 2002 Sep; 50(3):407-10. PubMed ID: 12205067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remarkable increase in fluoroquinolone-resistant Mycoplasma genitalium in Japan.
    Kikuchi M; Ito S; Yasuda M; Tsuchiya T; Hatazaki K; Takanashi M; Ezaki T; Deguchi T
    J Antimicrob Chemother; 2014 Sep; 69(9):2376-82. PubMed ID: 24894419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct assessment of possible mutations in the 23S rRNA gene encoding macrolide resistance in Chlamydia trachomatis.
    van Niekerk JM; van Loo IHM; Lucchesi M; Morré SA; Hoebe CJPA; Dukers-Muijrers NHTM; Wolffs PFG
    PLoS One; 2022; 17(5):e0265229. PubMed ID: 35536784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.